Studies have shown that TBK1 inhibition not only suppresses cancer progression by directly inhibiting cancer cell proliferation and survival but also suppresses cancer development by activating anti-tumor T cell immunity (Runde et al., 2022). Here, TBK1 is linked to neoplasm.